Cargando…
Current advances in digital cognitive assessment for preclinical Alzheimer's disease
There is a pressing need to capture and track subtle cognitive change at the preclinical stage of Alzheimer's disease (AD) rapidly, cost‐effectively, and with high sensitivity. Concurrently, the landscape of digital cognitive assessment is rapidly evolving as technology advances, older adult te...
Autores principales: | Öhman, Fredrik, Hassenstab, Jason, Berron, David, Schöll, Michael, Papp, Kathryn V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8290833/ https://www.ncbi.nlm.nih.gov/pubmed/34295959 http://dx.doi.org/10.1002/dad2.12217 |
Ejemplares similares
-
Unsupervised mobile cognitive testing for use in preclinical Alzheimer's disease
por: Papp, Kathryn V., et al.
Publicado: (2021) -
Diminished Learning Over Repeated Exposures (LORE) in preclinical Alzheimer's disease
por: Samaroo, Aubryn, et al.
Publicado: (2021) -
A classification algorithm for predicting progression from normal cognition to mild cognitive impairment across five cohorts: The preclinical AD consortium
por: Gross, Alden L., et al.
Publicado: (2017) -
Practice effects due to serial cognitive assessment: Implications for preclinical Alzheimer's disease randomized controlled trials
por: Goldberg, Terry E., et al.
Publicado: (2015) -
Cognitive impairment and decline in cognitively normal older adults with high amyloid-β: A meta-analysis
por: Baker, Jenalle E., et al.
Publicado: (2016)